<DOC>
	<DOC>NCT00323479</DOC>
	<brief_summary>The purpose of this study is to describe the joint symptoms and structural joint changes under anastrozole as adjuvant treatment in postmenopausal women with early breast cancer.</brief_summary>
	<brief_title>Arthralgia During Anastrozole Therapy for Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Post menopausal woman with a breast cancer and scheduled for an adjuvant treatment with anastrozole WHO performance status 0, 1 or 2 Provision of written informed consent Recurrence of breast cancer, inflammatory rheumatism treatment by chondromodulator, oral glucocorticoid, aromatase inhibitor, anti estrogen, Herceptin Diabetes treated by insulin Severe renal or hepatic disease Known hypersensitivity to anastrozole</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>breast cancer treatment</keyword>
	<keyword>joint disorders</keyword>
</DOC>